OR

OrbiMed — Seed & Series A VC Firm

VC
New York, New YorkWebsite

OrbiMed is a Seed, Series A venture capital firm based in New York, New York investing in Healthcare, Other, AI / ML. The firm has 109 portfolio companies in our records.

Portfolio
109 companies on record
Partners
11 listed
AUM
$500M
Stage
Seed, Series A
Sectors
Healthcare, Other, AI / ML
HQ
New York, New York
Check size
Not in our records

Last verified: 2026-10-22

How to approach: warm intro preferred
Stage

Seed, Series A

AUM

$500M

Portfolio

109+ companies

Team

11 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Major life sciences investor with broad biotech and pharma coverage. Relevant mainly when a partner is championing an early-stage therapeutics opportunity.

How OrbiMed invests

OrbiMed is a vc firm based in New York, New York. The firm invests at the Seed, Series A stages, with a focus on Healthcare, Other, AI / ML.

OrbiMed manages approximately $500M in assets. Our records include 3 funds raised by the firm.

OrbiMed has backed 109 companies in our records, including Keros Therapeutics, Kumquat Bio, Laekna Therapeutics.

Partners & Team

MH

Madeline Huber

Vice President

DB

David Bonita

General Partner

GC

Gordon Carl

General Partner

DW

David Wang

Managing Director

AK

Andrew Kanarek

Chief Risk Officer

TZ

Tal Zaks

Private Equity Partner

JP

Jeff Peters

Venture Partner

SP

Specific partner not identified in source

Partner

biotech
pharma
NY

Nate Yee

Principal

CN

Carter Neild

Managing Partner

KK

Kirsten Kearns

Head of Human Resources

Industry Focus

Invests In

Healthcare
Other
AI / ML

Funds

OrbiMed Fund III

$200M2023
investing

OrbiMed Fund II

$150M2019
investing

OrbiMed Fund I

$100M2015
fully deployed

Portfolio Companies (109)

Other

KE

Keros Therapeutics

KU

Kumquat Bio

LA

Laekna Therapeutics

LA

Lattice MedTech Private Limited

LA

Laxmi Dental

LE

Leal Therapeutics

AC

Accro Bioscience

Biopharma / immunology·Series C

Clinical-stage biotech developing therapeutics targeting regulatory cell death mechanisms for immune-mediated diseases

TH

The Oncology Institute

Healthcare services / oncology·Debt financing·An investment fund affiliated with OrbiMed Advisors

Community oncology provider and cancer-care services company

AC

Acutus Medical

AD

ADARx Pharmaceuticals

How to pitch OrbiMed
  • •Raising at Seed, Series A? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare, Other, AI / ML — the sectors they actively back.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Madeline Huber, Vice President.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if OrbiMed is a match for your startup

Upload your pitch deck to see how well you match with OrbiMed and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal